- Home
- Publications
- Publication Search
- Publication Details
Title
Somatic variation and cancer: therapies lost in the mix
Authors
Keywords
-
Journal
HUMAN GENETICS
Volume 130, Issue 1, Pages 79-91
Publisher
Springer Nature
Online
2011-06-04
DOI
10.1007/s00439-011-1010-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic Pathology: Challenges for Implementation
- (2011) Philip T Cagle et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML
- (2011) Daniel C. Link JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Charting a course for genomic medicine from base pairs to bedside
- (2011) Eric D. Green et al. NATURE
- Targeting the missing links for cancer therapy
- (2011) Kornelia Polyak et al. NATURE MEDICINE
- A close look at cancer
- (2011) Alison Farrell NATURE MEDICINE
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- Taming the dragon: genomic biomarkers to individualize the treatment of cancer
- (2011) Ian J Majewski et al. NATURE MEDICINE
- Cancer genomics: from discovery science to personalized medicine
- (2011) Lynda Chin et al. NATURE MEDICINE
- Predictive, personalized, preventive, participatory (P4) cancer medicine
- (2011) Leroy Hood et al. Nature Reviews Clinical Oncology
- Personalized cancer medicine: era of promise and progress
- (2011) Lisa Hutchinson Nature Reviews Clinical Oncology
- WIN Consortium—challenges and advances
- (2011) John Mendelsohn et al. Nature Reviews Clinical Oncology
- Implications of personalized medicine—perspective from a cancer center
- (2011) Thomas Tursz et al. Nature Reviews Clinical Oncology
- Biomarker studies: a call for a comprehensive biomarker study registry
- (2011) Fabrice Andre et al. Nature Reviews Clinical Oncology
- Methodological and practical challenges for personalized cancer therapies
- (2011) Ignacio I. Wistuba et al. Nature Reviews Clinical Oncology
- An accelerated pathway for targeted cancer therapies
- (2011) Mark McClellan et al. NATURE REVIEWS DRUG DISCOVERY
- Advances in the preclinical testing of cancer therapeutic hypotheses
- (2011) Giordano Caponigro et al. NATURE REVIEWS DRUG DISCOVERY
- Phase III and submission failures: 2007–2010
- (2011) John Arrowsmith NATURE REVIEWS DRUG DISCOVERY
- Genomics and the Continuum of Cancer Care
- (2011) Ultan McDermott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance to BRAF Inhibition in Melanomas
- (2011) David B. Solit et al. NEW ENGLAND JOURNAL OF MEDICINE
- Using genetics and genomics strategies to personalize therapy for cancer: Focus on melanoma
- (2010) Katherine L. Nathanson BIOCHEMICAL PHARMACOLOGY
- Molecular predictors of outcome in a phase 3 study of gemcitabine and erlotinib therapy in patients with advanced pancreatic cancer
- (2010) Gilda da Cunha Santos et al. CANCER
- ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time
- (2010) David E. Gerber et al. CANCER CELL
- Striving to Improve Outcomes in Oncology: Unmet Expectations in a Complex Disease
- (2010) S. E. Bates CLINICAL CANCER RESEARCH
- Translating Clinical Trials into Meaningful Outcomes
- (2010) P. M. LoRusso et al. CLINICAL CANCER RESEARCH
- AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the Use of Biomarkers in Cancer Drug Development
- (2010) S. N. Khleif et al. CLINICAL CANCER RESEARCH
- Identifying pancreatic cancer patients for targeted treatment: the challenges and limitations of the current selection process and vision for the future
- (2010) Shayna L Showalter et al. Expert Opinion on Drug Delivery
- Clinical Implications of the Cancer Genome
- (2010) Laura E. MacConaill et al. JOURNAL OF CLINICAL ONCOLOGY
- Selecting Systemic Cancer Therapy One Patient at a Time: Is There a Role for Molecular Profiling of Individual Patients With Advanced Solid Tumors?
- (2010) James H. Doroshow JOURNAL OF CLINICAL ONCOLOGY
- Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
- (2010) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Adaptive Clinical Trial Design: Has Its Time Come?
- (2010) N. J. Nelson JNCI-Journal of the National Cancer Institute
- Randomized Clinical Trials With Biomarkers: Design Issues
- (2010) B. Freidlin et al. JNCI-Journal of the National Cancer Institute
- When Are "Positive" Clinical Trials in Oncology Truly Positive?
- (2010) A. Ocana et al. JNCI-Journal of the National Cancer Institute
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer
- (2010) M. C. Villarroel et al. MOLECULAR CANCER THERAPEUTICS
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
- (2010) Cory M. Johannessen et al. NATURE
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
- (2010) Ramin Nazarian et al. NATURE
- International network of cancer genome projects
- (2010) Thomas J. Hudson (Chairperson) et al. NATURE
- Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
- (2010) Nallasivam Palanisamy et al. NATURE MEDICINE
- Understanding resistance to EGFR inhibitors—impact on future treatment strategies
- (2010) Deric L. Wheeler et al. Nature Reviews Clinical Oncology
- Gene and drug matrix for personalized cancer therapy
- (2010) Tim Harris NATURE REVIEWS DRUG DISCOVERY
- Personalized medicine in oncology: the future is now
- (2010) Richard L. Schilsky NATURE REVIEWS DRUG DISCOVERY
- Genomics drugs in clinical trials
- (2010) Jonathan Hall et al. NATURE REVIEWS DRUG DISCOVERY
- Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer
- (2009) B. Seruga et al. ANNALS OF ONCOLOGY
- Changing the Paradigm in Conducting Randomized Clinical Studies in Advanced Pancreatic Cancer: An Opportunity for Better Clinical Development
- (2009) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy
- (2009) Carmen J. Allegra et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
- (2009) Sumithra J. Mandrekar et al. JOURNAL OF CLINICAL ONCOLOGY
- Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment
- (2009) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- The cancer genome
- (2009) Michael R. Stratton et al. NATURE
- Molecular predictors of response to trastuzumab and lapatinib in breast cancer
- (2009) Francisco J. Esteva et al. Nature Reviews Clinical Oncology
- HER2-testing in 538 consecutive breast cancer cases using FISH and immunohistochemistry
- (2009) Anikó Kovács et al. PATHOLOGY RESEARCH AND PRACTICE
- Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples
- (2009) Laura E. MacConaill et al. PLoS One
- Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
- (2008) T. Byrski et al. BREAST CANCER RESEARCH AND TREATMENT
- Coordinated Epidermal Growth Factor Receptor Pathway Gene Overexpression Predicts Epidermal Growth Factor Receptor Inhibitor Sensitivity in Pancreatic Cancer
- (2008) A. Jimeno et al. CANCER RESEARCH
- Translating insights from the cancer genome into clinical practice
- (2008) Lynda Chin et al. NATURE
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Oncogenes and Cancer
- (2008) Carlo M. Croce NEW ENGLAND JOURNAL OF MEDICINE
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now